Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZE: Azithromycin for Early Pseudomonas Aeruginosa in Cystic Fibrosis
NCT02054156Phase 3Completed
- Start
- Jun 2014
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in Pseudomonas aeruginosa infection. Started Jun 2014; status: completed.
02
Drugs
azithromycin
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT02054156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054156.